We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $455M
1-Year Est. Return 218.66%
This Fund
S&P 500
This Quarter Est. Return
+66.19%
1 Year Est. Return
+218.66%
3 Year Est. Return
+1,489.77%
5 Year Est. Return
+4,348.98%
10 Year Est. Return
+169,910.37%
AUM
$455M
AUM Growth
+$57.7M
Cap. Flow
-$82.2M
Cap. Flow %
-18.09%
Top 10 Hldgs %
19.06%
Holding
153
New
50
Increased
18
Reduced
37
Closed
44

Sector Composition

Rank Sector Weight
1 Technology 34.16%
2 Healthcare 25.57%
3 Industrials 23.22%
4 Consumer Discretionary 9.43%
5 Financials 2.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAIR
101
Madison Air Solutions
MAIR
$13.2B
$1.37M 0.3%
+35,015
New +$1.36M
LGN
102
Legence Corp
LGN
$4.14B
$1.33M 0.29%
+15,580
New +$1.27M
CRDO icon
103
Credo Technology Group
CRDO
$43.7B
$1.14M 0.25%
+4,175
New +$825K
APEI icon
104
American Public Education
APEI
$842M
$1.12M 0.25%
+20,895
New +$1.15M
ATRO icon
105
Astronics
ATRO
$3.26B
$998K 0.22%
12,280
-36,704
-75% -$2.51M
PI icon
106
Impinj
PI
$5.2B
$801K 0.18%
+5,595
New +$730K
PL icon
107
Planet Labs
PL
$7.12B
$738K 0.16%
22,285
-190,140
-90% -$7.03M
XPO icon
108
XPO
XPO
$22.1B
$643K 0.14%
3,130
QNT
109
Quantinuum Inc
QNT
$1.84B
$409K 0.09%
+5,005
New +$322K
AEIS icon
110
Advanced Energy
AEIS
$10.9B
-23,736
Closed -$7.66M
ALHC icon
111
Alignment Healthcare
ALHC
$2.83B
-130,280
Closed -$2.3M
APGE icon
112
Apogee Therapeutics
APGE
$10.2B
-52,260
Closed -$4.4M
BBIO icon
113
BridgeBio Pharma
BBIO
$15B
-31,405
Closed -$2.33M
CAVA icon
114
CAVA Group
CAVA
$7.82B
-50,510
Closed -$4.09M
COHR icon
115
Coherent
COHR
$54.7B
-4,020
Closed -$958K
DNTH icon
116
Dianthus Therapeutics
DNTH
$5.92B
-12,410
Closed -$1.04M
ENSG icon
117
The Ensign Group
ENSG
$10.1B
-30,810
Closed -$6.21M
EYE icon
118
National Vision
EYE
$1.37B
-196,953
Closed -$5.1M
FCFS icon
119
FirstCash
FCFS
$9.51B
-16,965
Closed -$3.19M
FIGS icon
120
FIGS
FIGS
$2.56B
-137,180
Closed -$2.03M
FIVE icon
121
Five Below
FIVE
$13.4B
-42,639
Closed -$9.74M
FIX icon
122
Comfort Systems
FIX
$53.5B
-1,390
Closed -$1.92M
FN icon
123
Fabrinet
FN
$14.8B
-12,165
Closed -$6.34M
FRPT icon
124
Freshpet
FRPT
$3.4B
-53,125
Closed -$3.13M
GKOS icon
125
Glaukos
GKOS
$10.6B
-6,995
Closed -$753K

Similar funds

Lisanti Capital Growth's Q2 2026 Portfolio in Review

As of Q2 2026, Lisanti Capital Growth held 153 positions worth $455M, up 15% from $397M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Lisanti Capital Growth withdrew a net $82.2M in Q2 2026, closing 44 positions and reducing 37 holdings. Its most notable exit was Five Below, an estimated $9.74M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Lisanti Capital Growth opened a new position in Xometry worth $9.74M.

  • Lisanti Capital Growth's largest Q2 2026 buy was Xometry: 100,880 shares worth $9.74M.
  • Lisanti Capital Growth added most to Hinge Health in Q2 2026, an estimated $4.34M increase.
  • Lisanti Capital Growth's biggest Q2 2026 reduction was Sterling Infrastructure, cutting an estimated $10.7M.
  • Lisanti Capital Growth fully exited Five Below in Q2 2026, selling an estimated $9.74M.
  • Lisanti Capital Growth's ten largest holdings make up 19% of its $455M portfolio in Q2 2026.
  • Lisanti Capital Growth opened 50 new positions and closed 44 in Q2 2026.
  • Lisanti Capital Growth's portfolio value rose 15% quarter-over-quarter to $455M.

Based on Lisanti Capital Growth's 13F filing for Q2 2026, filed 10 Aug 2026.